MRS of ischemic/hypoxic brain disease.
Significant increases in magnetic field strengths and improvements in magnetic field homogeneity have made combined high-resolution magnetic resonance imaging (MRI) and multinuclear spectroscopy (MRS) feasible for investigating the relationship between biochemical and structural changes induced by ischemic brain disease. Magnetic resonance spectroscopy is the only noninvasive technique capable of measuring concentrations of high-energy phosphate metabolites, lactate, and other metabolically relevant compounds. Anticipated advances in localization of the volume of tissue from which spectra are obtained will enhance the clinical potential of MRS in the diagnosis of ischemic disease.
Kucharczyk
J
J
Department of Radiology, University of California, San Francisco 94143-0628.
Moseley
M
M
Kurhanewicz
J
J
Norman
D
D
D000818:Animals; D002545:Brain Ischemia / Q000175:diagnosis / Q000378:metabolism*; D002415:Cats; D006801:Humans; D002534:Hypoxia, Brain / Q000175:diagnosis / Q000378:metabolism*; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D010758:Phosphorus; D011379:Prognosis; D012307:Risk Factors
D010758:Phosphorus